Alize Pharma III alz-pharma.com


Public list: Pharma Startups (6570) Rare Diseases (230)

Alize Pharma 3 develops therapeutic peptides for rare endocrine and metabolic diseases. Alize Pharma 3 is building a balanced portfolio of products targeting significant unmet medical needs. Its first two assets are AZP-3601, a PTH analog for hypoparathyroidism, and AZP-3404, a peptide leveraging the biology of IGFBP2 for treating syndromes of severe insulin resistance.

Alize Pharma 3 develops therapeutic peptides for rare endocrine and metabolic diseases. Alize Pharma 3 is building a balanced portfolio of products targeting significant unmet medical needs. Its first two assets are AZP-3601, a PTH analog for hypopar...Show all

Company (Alive / Active)

Phone:

Fax:

15, chemin du Saquin
Espace Europeen, Building G
Ecully, 69130
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alize Pharma III $76.9M Jul 31, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alize Pharma III Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents